KR100377252B1 - Health food for anticancer - Google Patents
Health food for anticancer Download PDFInfo
- Publication number
- KR100377252B1 KR100377252B1 KR10-2000-0045211A KR20000045211A KR100377252B1 KR 100377252 B1 KR100377252 B1 KR 100377252B1 KR 20000045211 A KR20000045211 A KR 20000045211A KR 100377252 B1 KR100377252 B1 KR 100377252B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- powder
- slugs
- extract
- composition
- Prior art date
Links
- 230000001093 anti-cancer Effects 0.000 title claims abstract description 39
- 235000013402 health food Nutrition 0.000 title claims abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 87
- 239000000284 extract Substances 0.000 claims abstract description 59
- 239000000203 mixture Substances 0.000 claims abstract description 59
- 241000237858 Gastropoda Species 0.000 claims abstract description 57
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 35
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 35
- 240000000249 Morus alba Species 0.000 claims abstract description 20
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 20
- 235000014066 European mistletoe Nutrition 0.000 claims abstract description 18
- 235000012300 Rhipsalis cassutha Nutrition 0.000 claims abstract description 18
- 241001106462 Ulmus Species 0.000 claims abstract description 18
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims abstract description 14
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000011511 Diospyros Nutrition 0.000 claims abstract description 12
- 244000236655 Diospyros kaki Species 0.000 claims abstract description 12
- 229910052802 copper Inorganic materials 0.000 claims abstract description 12
- 239000010949 copper Substances 0.000 claims abstract description 12
- 238000002386 leaching Methods 0.000 claims abstract description 11
- 244000061508 Eriobotrya japonica Species 0.000 claims abstract description 4
- 241000130993 Scarabaeus <genus> Species 0.000 claims abstract description 4
- 244000152640 Rhipsalis cassutha Species 0.000 claims abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 8
- 244000000231 Sesamum indicum Species 0.000 claims description 8
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 240000002853 Nelumbo nucifera Species 0.000 claims description 6
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 6
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 6
- 241000931705 Cicada Species 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims description 3
- 241000131091 Lucanus cervus Species 0.000 claims description 3
- 240000004885 Quercus rubra Species 0.000 claims description 2
- 235000009135 Quercus rubra Nutrition 0.000 claims description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims description 2
- 239000000052 vinegar Substances 0.000 claims description 2
- 235000021419 vinegar Nutrition 0.000 claims description 2
- 244000241257 Cucumis melo Species 0.000 claims 1
- 241000222336 Ganoderma Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 241000254137 Cicadidae Species 0.000 abstract 1
- 241000131077 Lucanidae Species 0.000 abstract 1
- 230000009471 action Effects 0.000 description 17
- 235000008216 herbs Nutrition 0.000 description 17
- 241000221012 Viscum Species 0.000 description 15
- 231100000419 toxicity Toxicity 0.000 description 14
- 230000001988 toxicity Effects 0.000 description 14
- 239000003814 drug Substances 0.000 description 13
- 241001092070 Eriobotrya Species 0.000 description 10
- 206010028980 Neoplasm Diseases 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 230000000144 pharmacologic effect Effects 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 230000012010 growth Effects 0.000 description 7
- 241000382353 Pupa Species 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 241000124033 Salix Species 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- 241000208140 Acer Species 0.000 description 2
- ZHGNHOOVYPHPNJ-UHFFFAOYSA-N Amigdalin Chemical compound FC(F)(F)C(=O)OCC1OC(OCC2OC(OC(C#N)C3=CC=CC=C3)C(OC(=O)C(F)(F)F)C(OC(=O)C(F)(F)F)C2OC(=O)C(F)(F)F)C(OC(=O)C(F)(F)F)C(OC(=O)C(F)(F)F)C1OC(=O)C(F)(F)F ZHGNHOOVYPHPNJ-UHFFFAOYSA-N 0.000 description 2
- 235000018185 Betula X alpestris Nutrition 0.000 description 2
- 235000018212 Betula X uliginosa Nutrition 0.000 description 2
- 241000219112 Cucumis Species 0.000 description 2
- IHTCCHVMPGDDSL-ZJNDIJRCSA-N Cucurbitacin A Natural products O=C([C@@](O)(C)[C@H]1[C@@H](O)C[C@]2(C)[C@]1(C)CC(=O)[C@]1(CO)[C@H]2CC=C2C(C)(C)C(=O)[C@H](O)C[C@@H]12)/C=C/C(OC(=O)C)(C)C IHTCCHVMPGDDSL-ZJNDIJRCSA-N 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- WWNNZCOKKKDOPX-UHFFFAOYSA-N N-methylnicotinate Chemical compound C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241000219492 Quercus Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 208000002495 Uterine Neoplasms Diseases 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- -1 epiprideranol Chemical compound 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 229940126601 medicinal product Drugs 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 206010046766 uterine cancer Diseases 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- NDYMQXYDSVBNLL-LAMASETHSA-N (23E)-25-acetyloxy-2,16alpha,20-trihydroxy-9beta-methyl-19-nor-10alpha-lanosta-1,5,23-triene-3,11,22-trione Chemical compound C([C@H]1[C@]2(C)C[C@@H](O)[C@@H]([C@]2(CC(=O)[C@]11C)C)[C@@](C)(O)C(=O)C=CC(C)(C)OC(=O)C)C=C2[C@H]1C=C(O)C(=O)C2(C)C NDYMQXYDSVBNLL-LAMASETHSA-N 0.000 description 1
- SRPHMISUTWFFKJ-VOKXYEOFSA-N (23E)-2beta,16alpha,20,25- tetrahydroxy-9beta-methyl-19-nor-10alpha-lanosta-5,23-diene-3,11,22-trione Chemical compound C([C@H]1[C@]2(C)C[C@@H](O)[C@@H]([C@]2(CC(=O)[C@]11C)C)[C@@](C)(O)C(=O)C=CC(C)(O)C)C=C2[C@H]1C[C@H](O)C(=O)C2(C)C SRPHMISUTWFFKJ-VOKXYEOFSA-N 0.000 description 1
- IXQKXEUSCPEQRD-NRNCYQGDSA-N (2S,4R,23E)-2,16beta,20-trihydroxy-9beta,10,14-trimethyl-1,11,22-trioxo-4,9-cyclo-9,10-secocholesta-5,23-dien-25-yl acetate Chemical compound C([C@H]1[C@]2(C)C[C@@H](O)[C@@H]([C@]2(CC(=O)[C@]11C)C)[C@@](C)(O)C(=O)C=CC(C)(C)OC(=O)C)C=C2[C@H]1C[C@H](O)C(=O)C2(C)C IXQKXEUSCPEQRD-NRNCYQGDSA-N 0.000 description 1
- XCDQFROEGGNAER-VYFOYESCSA-N (3r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-4,4a,6a,6b,8a,11,11,14a-octamethyl-1,2,3,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-hexadecahydropicen-3-ol Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3CC[C@@H](O)[C@@H]1C XCDQFROEGGNAER-VYFOYESCSA-N 0.000 description 1
- GXWUEMSASMVWKO-GNLHUFSQSA-N (4as,6ar,6as,6br,10s,12ar,14br)-10-[(2s,3r,4s,5s)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid Chemical compound O([C@@H]1[C@@H](O)[C@@H](O)CO[C@H]1O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CCC2C1(C)C)C)(C)CC[C@]1(CCC(C[C@@H]14)(C)C)C(O)=O)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GXWUEMSASMVWKO-GNLHUFSQSA-N 0.000 description 1
- NDYMQXYDSVBNLL-UHFFFAOYSA-N (9beta,10alpha,16alpha,23E)-25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-19-norlanosta-1,5,23-triene-3,11,22-trione Natural products CC12C(=O)CC3(C)C(C(C)(O)C(=O)C=CC(C)(C)OC(=O)C)C(O)CC3(C)C1CC=C1C2C=C(O)C(=O)C1(C)C NDYMQXYDSVBNLL-UHFFFAOYSA-N 0.000 description 1
- SRPHMISUTWFFKJ-UHFFFAOYSA-N (E)-2beta,16alpha,20,25-tetrahydroxy-9-methyl-19-nor-9beta,10alpha-lanosta-5,23-diene-3,11,22-trione Natural products CC12C(=O)CC3(C)C(C(C)(O)C(=O)C=CC(C)(O)C)C(O)CC3(C)C1CC=C1C2CC(O)C(=O)C1(C)C SRPHMISUTWFFKJ-UHFFFAOYSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- 235000004422 Acer negundo Nutrition 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 241000191985 Anas superciliosa Species 0.000 description 1
- 241000041619 Aristolochia kaempferi Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- IHTCCHVMPGDDSL-IVNGUWCNSA-N Cucurbitacin A Chemical compound C([C@H]1[C@]2(C)C[C@@H](O)[C@@H]([C@]2(CC(=O)[C@]11CO)C)[C@@](C)(O)C(=O)/C=C/C(C)(C)OC(=O)C)C=C2[C@H]1C[C@H](O)C(=O)C2(C)C IHTCCHVMPGDDSL-IVNGUWCNSA-N 0.000 description 1
- CVKKIVYBGGDJCR-SXDZHWHFSA-N Cucurbitacin B Natural products CC(=O)OC(C)(C)C=CC(=O)[C@@](C)(O)[C@@H]1[C@@H](O)C[C@]2(C)C3=CC[C@@H]4C(C)(C)C(=O)[C@H](O)C[C@@]4(C)[C@@H]3CC(=O)[C@@]12C CVKKIVYBGGDJCR-SXDZHWHFSA-N 0.000 description 1
- DGIGXLXLGBAJJN-BTCRBLTISA-N Cucurbitacin C Natural products CC(=O)OC(C)(C)C=CC(=O)[C@@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](CC[C@H](O)C4(C)C)[C@@]3(CO)C(=O)C[C@]12C DGIGXLXLGBAJJN-BTCRBLTISA-N 0.000 description 1
- DGIGXLXLGBAJJN-TUOUHCSQSA-N Cucurbitacin C Chemical compound C([C@H]1[C@]2(C)C[C@@H](O)[C@@H]([C@]2(CC(=O)[C@]11CO)C)[C@@](C)(O)C(=O)/C=C/C(C)(C)OC(=O)C)C=C2[C@H]1CC[C@H](O)C2(C)C DGIGXLXLGBAJJN-TUOUHCSQSA-N 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- RKWHWFONKJEUEF-GQUPQBGVSA-O Cyanidin 3-O-glucoside Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 RKWHWFONKJEUEF-GQUPQBGVSA-O 0.000 description 1
- QZJJDOYZVRUEDY-UHFFFAOYSA-N Dihydrocucurbitacin B Natural products CC12C(=O)CC3(C)C(C(C)(O)C(=O)CCC(C)(C)OC(=O)C)C(O)CC3(C)C1CC=C1C2CC(O)C(=O)C1(C)C QZJJDOYZVRUEDY-UHFFFAOYSA-N 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 241000995070 Nirvana Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241001425800 Pipa Species 0.000 description 1
- 206010037394 Pulmonary haemorrhage Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 244000020191 Salix babylonica Species 0.000 description 1
- 235000002493 Salix babylonica Nutrition 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 241000880950 Viburnum dentatum Species 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- YTMNONATNXDQJF-UBNZBFALSA-N chrysanthemin Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 YTMNONATNXDQJF-UBNZBFALSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 239000002361 compost Substances 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- JTPLNLNCNOCZIB-UHFFFAOYSA-N cucurbitacin D Natural products CC(C)(O)C=CC(=O)C(C)(O)C1C(O)CC2C3CC=C4C(C)(C)C(=O)C(O)CC4(C)C3C(=O)CC12C JTPLNLNCNOCZIB-UHFFFAOYSA-N 0.000 description 1
- IVGSDBLLLAUYTL-UHFFFAOYSA-N cucurbitacin E Natural products CC(=O)OC(C)(C)C=CC(=O)C(C)(O)C1C(O)CC2(C)C3CC=C4C(C=C(O)C(=O)C4(C)C)C3(C)CCC12C IVGSDBLLLAUYTL-UHFFFAOYSA-N 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- FWTBRZMBHIYQSW-UHFFFAOYSA-N epifriedelanol Natural products CC1C(O)C(O)CC2C1(C)CCC3C2(C)CCC4(C)C5CC(C)(C)CCC5(C)C(O)CC34C FWTBRZMBHIYQSW-UHFFFAOYSA-N 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000008236 heating water Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 1
- 229910052683 pyrite Inorganic materials 0.000 description 1
- 239000011028 pyrite Substances 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000004565 tumor cell growth Effects 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 235000020990 white meat Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 항암 작용이 탁월한 건강식품에 관한 것으로, 항암 또는 이와 관련되는 약리 작용이 우수한 구지뽕나무 분말 10 중량%와 느릅나무 분말 10 중량%와 참빗살나무 분말 5 중량%와 어성초 분말 5 중량%와 겨우살이 분말 5 중량%와 동과씨 분말 2 중량%와 맹감 뿌리 분말 6 중량%와 비파 분말 5 중량%와 황토 45 중량%를 혼합한 혼합물과 과체 추출액 3 중량%와 주사련 추출액 4 중량%를 혼합한 조성물을 사료로 적용하여 양식한 굼벵이류(매미, 풍뎅이, 사슴벌레, 뽕나무나방의 유충)에서 열수침출한 추출물과, 상기 조성물에서 재배한 영지버섯을 열수침출한 추출물을 혼합하여 구성되는 항암에 특히 큰 효과가 있는 건강식품을 제공하고자 하는 것이다.The present invention relates to a health food with excellent anticancer activity, 10% by weight of Gujimi mulberry powder, 10% by weight of elm tree powder, 5% by weight of elmwood powder, 5% by weight of Echo herb powder and mistletoe A mixture of 5% by weight of powder, 2% by weight of copper and seed powder, 6% by weight of persimmon root powder, 5% by weight of loquat powder and 45% by weight of ocher, 3% by weight of overextract and 4% by weight of extract Anticancer consisting of a mixture of hydrothermally leached extracts from slugs (Cicadas, Scarabs, stag beetles, larvae of larvae) cultured by applying the composition as a feed, and extracts obtained by hydrothermally leaching extracts of Ganoderma lucidum grown in the composition It is to provide a health food that has a great effect.
Description
본 발명에서는 항암 또는 이와 관련되는 약리 작용이 우수한 다수종의 천연 약재와 황토로 구성되는 약재 조성물을 사료로 적용하여 양식한 굼벵이류에서 열수침출한 추출물과, 상기 약재 조성물에서 재배한 영지버섯을 열수침출한 추출물로 구성되는 건강식품에 관한 것이다.In the present invention, by applying a medicinal composition consisting of a number of natural herbs and ocher with excellent anti-cancer or related pharmacological action as feed, the hydrothermal leaching extracts from slugs cultured, and Ganoderma lucidum grown in the medicinal composition It relates to a health food consisting of leached extract.
건강에 대한 관심이 높아지고 천연약재에 대한 인식이 바뀌면서 천연약재를 적용하여 제조되는 건강식품에 대한 관심이 고조되고 있으며 그 중에서도 항암작용이 우수한 건강식품에 대한 수요가 증가되고 있다.As interest in health and awareness of natural medicines change, interest in health foods manufactured by applying natural medicines is increasing, and among them, demand for health foods having excellent anticancer activity is increasing.
종래의 항암 건강식품은 항암 약리 작용이 우수한 단일종의 항암성 천연 약재를 천연상태 그대로 추출하고 분말, 환약, 추출액 등의 형태로 가공. 제조되는데 단일종의 천연약재로는 항암 작용과 관련되는 약리 작용이 제한되기 때문에 암과 관련된 각종 증상들을 치료하는 효과가 부족하며, 일반적으로 천연 약재류는 그 약효와 함께 고유의 독성까지 포함하고 있기 때문에 천연상태에서 그대로 추출한 건강식품을 복용하면 인체에 부작용을 미칠 수 있다는 문제점이 있다.Conventional anticancer health food extracts a single anticancer natural medicine with excellent anticancer pharmacological action as it is, and is processed in the form of powder, pills, extracts, and the like. It is manufactured because a single type of natural medicine is limited in pharmacological action related to anticancer activity, and thus lacks the effect of treating various symptoms related to cancer.In general, natural medicines contain their own toxicity and inherent toxicity. If you take a health food extracted from its natural state, there is a problem that can have side effects.
본 발명의 목적은 구지뽕나무 분말 10 중량%와 느릅나무 분말 10 중량%와 참빗살나무 분말 5 중량%와 어성초 분말 5 중량%와 겨우살이 분말 5 중량%와 동과씨 분말 2 중량%와 맹감 뿌리 분말 6 중량%와 비파 분말 5 중량%와 황토 45 중량%를 혼합한 혼합물과 과체 추출액 3 중량%와 주사련 추출액 4 중량%를 혼합한 조성물인 천연 약재90중량%와 황토10중량%로 구성되는 혼합물 80중량%와 물20중량%를 혼합한 다수종의 천연 약재류에 굼벵이를 일정한 기간 동안 배양하고 상기 굼벵이의 추출물을 이용하므로서 상기 혼합물의 항암 및 관련 작용은 유지하면서 상기 혼합물의 약성에 포함된 독성은 중화 또는 제거하여 항암 및 관련 작용이 탁월하고 인체에 대한 부작용이 없는 항암 건강식품을 제공하는데 있다.An object of the present invention is 10% by weight of Gujimi mulberry powder, 10% by weight of elm tree powder, 5% by weight of red oak tree powder, 5% by weight of Echo herb powder, 5% by weight of mistletoe powder and 2% by weight of copper and seed powder and persimmon root powder 6 A mixture consisting of 90% by weight of natural herbs and 10% by weight of ocher, a composition of a mixture of 5% by weight of loquat powder, 5% by weight of loquat powder and 45% by weight of ocher, and 3% by weight of overextract extract and 4% by weight of lotus leaf extract. By incubating slugs for a certain period of time in a number of natural medicinal products mixed with 20% by weight of water and using the extract of the slugs, the toxicity contained in the weakness of the mixture is maintained while maintaining anticancer and related actions of the mixture. Neutralizing or eliminating is to provide an anti-cancer health food that is excellent in anticancer and related actions and has no side effects on the human body.
본 발명은 항암 또는 이와 관련되는 각종 약리 작용이 우수한 다수종의 천연약재류와 황토로 구성되는 약재 조성물을 사료로 적용하여 굼벵이류를 배양하고 상기 굼벵이류를 열수침출한 굼벵이류 추출물과, 상기 약재 조성물에 영지버섯 균사체를 주입하여 재배한 영지버섯을 열수침출한 영지버섯 추출물을 혼합하여 구성함으로써 상기 천연 약재류의 항암 및 관련작용은 유지되면서 상기 약재류의 독성을 중화 또는 제거시키고자 하는 것이다.The present invention is applied to the medicinal composition consisting of a number of natural medicinal herbs and ocher with excellent anti-cancer or various pharmacological action associated with the feed cultivation of slugs and the extract of the slugs hydrothermally leached the slugs, and the medicinal herbs It is intended to neutralize or eliminate the toxicity of the medicinal herb while maintaining the anticancer and related actions of the natural medicinal herbs by mixing the Ganoderma lucidum mycelium into the composition by mixing the Ganoderma lucidum extract obtained by hydrothermal leaching the Ganoderma lucidum mushroom.
본 발명을 구성하기 위해서는 암세포를 억제 또는 제거하는 항암 작용뿐만 아니라 암에 수반되는 당료, 황달 등과 같은 여러 증상들을 치료하는 약재류를 적용해야 한다. 약재 조성물에 적용되는 천연 약재류는 항암 작용뿐만 아니라 이와 관련된 증상들을 치료하는 약리 작용을 발휘하기 위해 여러 종류의 천연약재가 적용 되야 하고 각각의 천연 약재류에 포함된 독소는 중화 또는 제거하기 위해, 상기 약재 조성물을 사료로 적용하여 굼벵이류를 배양함으로서 상기 약재의 약성을 굼벵이의 몸속에 취택 저장하고 독성은 굼벵이의 몸속에서 중화 또는 제거되도록 한다.In order to construct the present invention, it is necessary to apply medicinal herbs to treat various symptoms such as glucose, jaundice and the like accompanying cancer, as well as anticancer action to inhibit or eliminate cancer cells. Natural medicinal herbs applied to the medicinal composition has to be applied to various kinds of natural medicinal herbs in order to exert not only anti-cancer action, but also pharmacological action to treat the symptoms associated with each other, and toxins contained in each natural medicinal herb to neutralize or eliminate, By applying the medicinal composition as a feed and culturing slugs, the medicinal properties of the medicinal herbs are stored in the slug's body and the toxicity is neutralized or eliminated in the slug's body.
상기와 같은 조건을 만족시키기 위한 천연 약재, 구지뽕나무 분말 10 중량%와 느릅나무 분말 10 중량%와 참빗살나무 분말 5 중량%와 어성초 분말 5 중량%와 겨우살이 분말 5 중량%와 동과씨 분말 2 중량%와 맹감 뿌리 분말 6 중량%와 비파 분말 5 중량%와 황토 45 중량%를 혼합한 혼합물과 과체 추출액 3 중량%와 주사련 추출액 4 중량%를 혼합한 조성물인 천연 약재90중량%와 황토10중량%로 구성되는 혼합물 80중량%와 물20중량%를 혼합하고 굼벵이를 배양하도록 하며 상기 굼벵이의 배양기간은 일정한 시간(42~48월) 이상을 요구한다.Natural medicinal herbs to satisfy the above conditions, 10% by weight of Gujimi mulberry powder, 10% by weight of elm tree powder, 5% by weight of sesame tree powder, 5% by weight of Echochocho powder, 5% by weight of mistletoe powder and 2% of copper seed powder %, 6% by weight persimmon root powder, 5% by weight loquat powder, and 45% by weight loess, a composition containing 3% by weight of overextract extract and 4% by weight of extract of Lotus leaf extract and 10% by weight of ocher The mixture consisting of 80% by weight and 20% by weight of water is mixed and the slugs are incubated. The incubation period of the slugs requires a certain time (42-48 months) or more.
상기와 같이 굼벵이의 배양시간은 굼벵이가 그 체내에 고농도 약성을 함축할 수 있는 시간과 상기 약재가 가지는 독성을 소거할 수 있는 최소한의 시간(36월)이 요구되며, 상기와 같은 최소한의 배양시간은 약성을 체득한 굼벵이가 최대한의 약성을 제공하기 위한 것이다. 상기와 같이 굼벵이가 최대한의 약성을 가지는 최소한의 시간은 36월~42월을 필요로 한다.As described above, the incubation time of the slugs requires a time when the slugs can imply high concentrations of weakness in the body and a minimum time (36 months) to eliminate the toxicity of the medicines. Is to provide maximum weakness by the slugs that have learned the weakness. As described above, the minimum time that slugs have the greatest weakness requires 36 months to 42 months.
따라서 굼벵이의 배양기간과 약성은 비례한다.일반적인 굼벵이의 생활 조건에서 매미굼벵이를 제외한 굼벵이가 번데기로 되는데 소용되는 기간은 24월 정도에 불과하므로 일반적인 생활 조건하에서는 본 발명에서 필요로하는 굼벵이의 최대 약성을 기대할 수 없으므로, 배양기간중 성장을 지연시키는 온도(5~10℃)를 유지하여 굼벵이 류의 배양기간을 연장시키도록 한다.Therefore, incubation period and weakness of slugs are proportional. In general slugs except for cicada slugs, the slugs are chrysalis, which are only used for about 24 months. Since it can not be expected to maintain the temperature (5 ~ 10 ℃) to delay the growth during the incubation period to extend the incubation period of slugs.
본 발명은 천연 약재인 구지뽕나무 분말 10 중량%와 느릅나무 분말 10 중량%와 참빗살나무 분말 5 중량%와 어성초 분말 5 중량%와 겨우살이 분말 5 중량%와 동과씨 분말 2 중량%와 맹감 뿌리 분말 6 중량%와 비파 분말 5 중량%와 황토 45 중량%를 혼합한 혼합물과 과체 추출액 3 중량%와 주사련 추출액 4 중량%를 혼합한 조성물과 상기 조성물의 10중량%의 황토로 구성되며 상기 약재중 구지뽕나무, 느릅나무, 참빗살나무, 어성초, 겨우살이, 동과씨, 맹감뿌리, 비파는 0.2~2㎜ 크기의 분말로 구성되고 과체와 주사련은 열수에 의한 추출액으로 구성하여 상기 분말과 추출액과, 황토를 혼합한 조성물을 사료로 적용하여 배양한 굼벵이류(매미, 풍뎅이, 사슴벌레, 뽕나무나방의 유충)를 열수에서 침출하여 추출한 굼벵이 추출물과, 상기 약재 조성물에 영지버섯 균사체를 주입하여 재배한 영지버섯을 열수에서 침출하여 추출한 영지버섯 추출물을 혼합하여 구성되는 항암 건강식품이 제공된다.The present invention is a natural medicinal herb 10% by weight, 10% by weight of elm tree powder, 10% by weight of elm tree powder, 5% by weight of sesame seedlings, 5% by weight of eochocho powder, 5% by weight of mistletoe powder, 2% by weight of copper and seed powder and persimmon root powder 6 wt%, loquat powder 5 wt% and ocher 45 wt%, a mixture of 3% by weight of the over-extract extract and 4% by weight of the extract extract and 10% by weight of the loess of the composition Koji mulberry tree, elm tree, sesame tree, eoseongcho, mistletoe, copper seed, blind persimmon root, loquat is composed of 0.2 ~ 2㎜ size powder, and the overweight and lotus leaf is composed of the extract by hot water and the powder and extract, Slugs extracted by leaching the slugs (Cicada, Scarab, Stag beetle, Mulberry moth larva) cultured by applying the composition mixed with ocher in hot water and Ganoderma lucidum mycelium in the medicinal composition Provided is an anti-cancer health food consisting of a mixture of Ganoderma lucidum extract extracted by leaching the Ganoderma lucidum cultivated by injection in hot water.
본 발명에 이용되는 재료의 성질과 성분을 분석하면,1. 구지뽕나무는 항암본초에 의하면, 구지뽕나무는 성(性)이 평(平)하고 맛은 쓰며 청숙(淸熟)하고 량혈(凉血)한다.Analyzing the properties and components of the materials used in the present invention, 1. Guji mulberry according to the anti-cancer herb, Guji mulberry is flat (sex), taste is bitter, cleansing (mature) and mass blood (凉血).
원식물은 뽕나무과의 구지뽕나무로서 목림(木林), 뿌리, 천파석, 수피, 줄기와 잎과 열매를 약으로 이용하며, 뿌리에는 플라보노이드, 글리코시드, 아미노산, 유기산, 당분, 모린 등이 함유되어 있다고 설명하고 있다.The original plant is the old mulberry tree of the mulberry family and uses wood, root, cheonpaseok, bark, stems, leaves and fruits as medicines, and the root contains flavonoids, glycosides, amino acids, organic acids, sugars, molines, etc. Explaining.
약리는 어혈(瘀血)을 부수고 월경을 통하게하며 임탁(淋濁)을 다스리고 오랜 어혈이 맺힌 것과 결석(結石)을 없앤다.Pharmacology breaks blood (혈), through menstruation, governs imak (淋 濁), eliminates the formation of old blood and stone (結石).
근골(筋骨)을 튼튼히 하며 활혈(活血)한다.Strengthen the musculature (筋骨) and is active (blood).
부인의 붕중혈결(崩中血結)을 다스린다.It governs the wife's middle blood.
구지뽕나무의 약리 작용은,Pharmacological action of old mulberry tree,
㉮. 자목, 근경, 목림에서 추출한 플라본과 에타놀엑기스는 흰생지의 육류(肉瘤)와 자궁암에 30%의 억제력이 있다.Iii. Flavones and ethanol extracts from woody, rhizome, and woody forests are 30% inhibitory to white meat and uterine cancer.
㉯. 체외 실험에 의해 식도암세포에 세포독상작용(細胞毒狀作用)이 발생하였다.Iii. In vitro experiments showed cytotoxicity to esophageal cancer cells.
㉰. 흰생지에 열반법진통 실험에 의해 진통효과가 있었다.Iii. The analgesic effect was observed in the white dough by nirvana method.
2. 느릅나무는 탄닌(tanin), 카테친(catechin), 아피오푸어라노사이드 (apiofuranoside)등의 성분이 있고, 약성은 감평(甘平)의 맛이 있다.2. Elm has tannin, catechin, and apiofuranoside, and its weakness is Gapyeong.
느릅나무의 약리는 미상이나, 응용은 리수(利水), 거담(去痰), 불면증, 소종에 이용되며, 사산, 낙태, 세포활성이 활발하여 새살이 빨리 생성되며, 환부에 부착하면 고름의 추출이 용이하다.Pharmacology of the elm tree is unknown, but its application is used in Lisu, expectoration, insomnia, and small species. It is easy.
3. 참빗살나무는 일명 화살나무라고 하며 가지를 약으로 이용하며, 성분은 크리산쎄민(chrysanthemin), 벤조익 아시드(benzoic acid), 프리데라놀 (friedelanol),에피프리데라놀(epifriedelanol), 듈시톨(dulcitol) 등이 있다.3. A true bark tree is called an arrow tree and its branches are used as medicines. The components are chrysanthemin, benzoic acid, friedelanol, epiprideranol, Dulcitol and the like.
참빗살나무의 약리는,Pharmacology of the bark,
혈당 및 요당을 감소시키고, 체중의 증가, 랑게르한스성 베타 증식에 효과가 있고, 신경통과 지혈, 월경통, 암치료제 등에 응용된다.It is effective in reducing blood sugar and urine glucose, weight gain, and Langerhans beta proliferation, and is applied to neuralgia, hemostasis, dysmenorrhea, and cancer treatments.
4. 어성초 약리는,4. eosungcho pharmacology,
전액(煎液)은 칼륨염과 쿠엘시트린(quercitrin)에 의하여 우수한 이뇨작용이 있으며, 항곰팡이 작용과 백선균에 대한 항균성이 있다.Whole liquid (煎 液) has excellent diuretic effect by potassium salt and quercitrin, antifungal action and antibacterial activity against ringworm.
약의 응용은,The application of the medicine,
폐의 결실을 발산시키며, 청혈, 해독, 악창, 중독치료, 폐옹의 토혈에 이용된다.It is used to clear the lungs, and is used for blood clotting, detoxification, swelling, poisoning, and pulmonary bleeding.
5. 겨우살이는 버드나무,수양버들, 단풍나무 들에 기생하며 약으로 이용하는 것은 상기생(桑寄生)과 겨우살이며, 상기생(桑寄生)은 뽕나무, 장뇌나무, 사이나무(沙梨), 묏대추나무, 용안나무에 기생하며, 겨우살이는 느릅나무, 자작나무, 버드나무, 단풍나무, 황철나무에 기생한다.5. Mistletoe will live on the willow, weeping willow, and maple trees, and the medicine is used for the above life and mistletoe, and the above life is mulberry, camphor tree, cypress, jujube tree, longan It is parasitic on trees and mistletoes on elm, birch, willow, maple and pyrite.
겨우살이의 주성분은 올레아노산(oleanolic)이고, 상기생(桑寄生)의 주성분은 쿠에르체틴(quercetin)과 아비쿨라린(avicularin)으로 구성되었다.The main component of mistletoe was oleanolic, and the main component of the above-mentioned raw material consisted of quercetin and abicurin.
약리- 상기생(桑寄生)을 열수침출물의 좀흰생쥐육류(肉瘤)의 억제율은 39.5%의 효과가 있고, 겨우살이 열수침출물의 좀흰생쥐육류(肉瘤)의 억제율은 77.9%의 효과가 있었다.Pharmacology-The inhibitory effect of the hot-water leachate on the white mucus meat was 39.5%, and the inhibition rate of the hot-water leachate on the white mucus meat was 77.9%.
본초구진(本草求眞)에 상기생(桑寄生)의 설명을 상기생(桑寄生)은 보신보혈요제(補腎補血要制)이다 라고 하였고,The description of the above life in the main chojinjin (상기 生) said that said life is a new blood urea (보 要 制),
본초종신(本草從新)에 음허를 다스리며 조양하고 골절을 이하며 경수를 통케하고 보혈활혈하며 안태하고 진통한다. 라고 소개하고 있다.Healing, nurturing, subcutaneous fracture, hard water, vigorous blood, stabilizing and analgesia. I introduce it.
6. 동과자6. Confectionery
동과는 박과의 한해살이 풀로서 "동과자는 피부의 주근깨를 없애고 살결을 윤택하게 한다."라고 대명일화제가본초(大明日華諸家本草)에서 평하고 있으며, 본초술구(本草述鉤)에서는 "심경의 온열 소변임통(小便淋痛)을 다스리고, 비면주사(鼻面酒渣)를 없애며 장초를 다스리고 위내의 옹종치료에 효과가 있고, 동과는 열이 있는 자에게 이로우며 냉이 있는 자에게 살이 빠지게 한다. 라고 기록되어 있다.As a year-round herb of the fruit family, the "sweets remove the freckles of the skin and make the skin smooth." Daemyung Ilhwa has been reviewed in Boncho, and in the Herb Garden, It is effective in controlling the urinary tract of the heart, the elimination of intestinal injection, the control of the intestines, and the treatment of carbuncles in the stomach. It is written.
동과자에는 사포닌(saponin), 지방유, 요소(尿素) 등이 함유되고 소량의 아데닌(adnine), 트리고넬린(trigonelline)이 함유되어있다.Confectionery contains saponin, fatty oil, urea, and a small amount of adenine and trigonelline.
7. 맹감뿌리7. Blind Root
주로 뿌리를 이용하며 진해, 거담, 건위, 조혈의 효과가 있다.Mainly using the root, Jinhae, expectoration, healthy, hematopoietic effect.
8. 비파8. Pipa
잎을 주로 이용하며 아미그달린(AMYGDALIN), 아솔릭아시드(ARSOLICACID), 올레아놀릭아시드(OLEANOLICACID), 마스리닉 아시드(MASLINICACLD)이 함유되어 있으며, 진해, 거담, 지갈약으로 이용된다.It mainly uses leaves and contains amigdalin (AMYGDALIN), asolic acid (ARSOLICACID), oleanolic acid (OLEANOLICACID) and maslinic acid (MASLINICACLD).
9. 주사련9. Syringe
진통제로 이용하며 맛은 쓰고 매우며 성은 차다. 어혈을 풀며 지통한다.Used as a painkiller, taste is very bitter and cold. Loosen the blood and pain.
아리스톨로시아 카엠페리윌드(aristolochia kaempferiwilld)의 성분이 있다.There is an ingredient of aristolochia kaempferiwilld.
아리스토록키산의 작용에 의하여 항암활성이 있으며 백혈구의 박테리오파제탄식기능의 촉진 기능이 있다.It has anticancer activity by the action of aristolockic acid and promotes bacteriopazetanic function of leukocytes.
10. 과체10. Overweight
과체는 개똥참외 꼭지를 말린 것으로 쿠쿠르비타신(cucurbitacin)A,B,C,D,E가 함유되어 있으며 황달, 부종, 거담, 등에 활용된다.느릅나무와 참빗살나무와 어성초와 겨우살이와 동과씨와 맹감 뿌리와Overweight is dried dried melon faucet and contains cucurbitacin A, B, C, D and E and is used for jaundice, edema, expectoration, etc. Elm, True Beetle, Estuary, Mistletoe and Beast With seeds and persimmon roots
비파는 각각 별도로 세척하여 완전히 건조한 다음 분쇄기로 분쇄(0.2~2㎜)하여 분말화한다. 주사련과 과체는 반응기(反應機) 내부의 열수에서 달이(가열하는)는 열수침출법으로 추출한 추출액(5~7%의 농도)을 구성한다. 상기 재료들 중에서 분말 재료와 황토를 교반기에 넣고 1차 교반하여 혼합(1/10의 황토)하고 주사련 혼홉액과 과체 추출액의 혼합액을 10:2로 혼합하고 교반하여 혼합물인 약재 조성물을 구성한다.Loquats are washed separately, completely dried, and then pulverized with a grinder (0.2-2 mm) to powder. Syringes and fruit bodies constitute an extract (concentration of 5-7%) extracted by hot water leaching in the hot water inside the reactor. Among the above materials, powder material and loess are put in a stirrer and mixed by first stirring (1/10 of loess), and the mixed solution of Syringe horn hop solution and excess extract is mixed at 10: 2 and stirred to form a medicinal composition as a mixture. .
굼벵이류의 배양은 온도 조절이 가능한 배양기에 상기 약재 조성물의 분말을 일정한 두께로 살포하고 상기 분말 위에 일정한 밀도(일정한 넓이에 일정한 굼벵이수의 비율)로 굼벵이류를 이식시키고 상기 굼벵이류의 성장 속도를 저하시키기 위하여 배양소 내부의 온도를 5∼10 ℃의 범위로 유지하여 배양하며 굼벵이류가 번데기화되는 시기에는 번데기화를 지연시키기 위하여 배양소 내부의 온도를 5∼6 ℃로 하강시켜 굼벵이류를 배양한다. 굼벵이류의 배양기간중 배양소의 온도가 5 ℃ 미만이면 굼벵이류가 동사하거나 배양이 완전히 정지되고 10 ℃를 초과하면 굼벵이류의 성장 속도가 지나치게 빨라져 조기에 번데기화 된다. 굼벵이의 성장이 완료되면 각각의 굼벵이는 3∼5 g의 중량으로 성장한다. 배양소에서 굼벵이류는 항암 효과를 향상시키기 위하여 배양기간이 증가될수록 항암 효과가 증가되기 때문에 굼벵이를 5~10℃로 배양하다가 굼벵이가 번데기화 시기가 되면 배양소 내부의 온도를 5∼6 ℃의 범위 내로 하강시켜 굼벵이의 번데기 화를 지연시켜서 굼벵이류의 배양기간을 연장시킨다.Cultivation of slugs is sprayed with a certain thickness of the powder of the medicinal composition in a temperature-controlled incubator, implanted slugs at a constant density (a certain ratio of slugs to a certain width) on the powder and increase the growth rate of the slugs In order to reduce the temperature inside the culture incubation in the range of 5 ~ 10 ℃, when the slugs are chrysalis, the temperature inside the culture is lowered to 5 ~ 6 ℃ in order to delay the pupalization to slow down the slugs Incubate. If the culture temperature of the slugs is less than 5 ° C., the slugs may be VERB or if the culture is completely stopped. If the slugs are more than 10 ° C., the growth rate of the slugs may be too fast, resulting in early pupa. When the slugs are finished growing, each slug grows to a weight of 3-5 g. In order to improve the anticancer effect, slugs are grown at 5 ~ 10 ℃ because they are incubated at 5 ~ 10 ℃. Lowering the range to delay the pupa's pupalization prolongs the incubation period of slugs.
번데기류 추출물은 열수에서 일정시간 달이(물을 가열하는 것)는 열수침출법으로 구성하는데 반응조 내부의 열수에 약재 조성물에 의하여 배양되어 성장이 완료된 굼벵이 류를 넣고 가열(100℃)하여 침출(각질 만 남게 되면)이 완료되면 가열을 중지하고 서서히 냉각하여 번데기류 추출물을 구성한다.Chrysalis extract is composed of hot water leaching method for a certain period of time (heating water) in hot water, which is cultivated by medicinal composition in hot water inside the reactor, and is added by heating (100 ° C.). When only keratin remains, the heating is stopped and gradually cooled to form a chrysalis extract.
영지버섯 배양소의 내부에 형성된 배양기에 상기 약재 조성물의 분말을 일정한 두께로 살포하고 상기 분말에 영지버섯 균사체를 주입하고 발아시켜 영지버섯을 재배하고 반응조 내부의 열수에 상기 영지버섯을 넣고 일정시간 가열하는 열수침출법으로 영지버섯 추출물을 구성하고, 상기 번데기류 추출물과 상기 영지버섯 추출물을 혼합하여 항암 건강식품을 구성한다.Spread the powder of the medicinal composition to a incubator formed in the Ganoderma lucidum culture in a constant thickness, injecting Ganoderma lucidum mycelium into the powder and germinating to cultivate Ganoderma lucidum mushrooms and put the Ganoderma lucidum mushroom in the hot water inside the reactor for a certain time The Ganoderma lucidum extract is composed by the hydrothermal leaching method, and the pupa extract and the Ganoderma lucidum extract are mixed to form an anticancer health food.
항암 및 관련 작용이 우수한 다수종의 천연 약재류로 구성되는 약재 조성물을 사료로 적용하여 일정한 온도에서 장기간에 걸쳐 배양되는 굼벵이류는 상기 천연약재류의 항암작용은 그대로 유지하면서 상기 약재류의 독성을 중화 또는 제거시키므로 상기 굼벵이류에서 열수침출한 굼벵이 추출물을 복용하는 경우 상기 약재류의 부작용이 발생하지 않는다. 상기 약재 조성물에 영지버섯 균사체를 주입하여 재배되는 영지버섯도 상기 천연약재류의 항암작용은 그대로 유지하면서 상기 약재류의 독성은 중화 또는 제거되고 또한, 영지버섯 자체가 항암작용이 우수하기 때문에 상기 약재 조성물에서 재배되는 영지버섯에서 열수침출한 추출물 역시 항암작용이탁월하고 인체에서 부작용이 발생하지 않는다.Slugs cultivated for a long time at a constant temperature by applying a medicinal composition consisting of a number of natural medicinal herbs excellent in anti-cancer and related actions to maintain the toxicity of the medicinal herbs while maintaining the anticancer action of the natural medicinal herbs as it is Since it neutralizes or eliminates the side effects of the medicines when taking the slug extracts hydrothermally leached from the slugs. Reishi mushroom cultivated by injecting the Ganoderma lucidum mycelium into the medicinal composition also neutralizes or eliminates the toxicity of the medicinal herbs while maintaining the anticancer activity of the natural medicinal herbs, and also because the Ganoderma lucidum itself has excellent anticancer activity Hot water leached extract from Ganoderma lucidum cultivated in the composition also has excellent anticancer activity and no side effects occur in the human body.
본 발명에 적용되는 천연 약재류와 황토와 영지버섯의 약리 작용은 다음과 같다.Pharmacological action of natural herbs and loess and Ganoderma lucidum applied to the present invention is as follows.
상기에서 설명한 바와 같이 구지뽕나무는 그 추출물이 암억제 작용과 진통작용이 우수하며 특히 상기 나무에 포함된 플라본은 암세포에 대한 세포독성 작용이 탁월하다. 느릅나무는 그 추출물이 암세포 및 고름을 제거하며 암세포 및 고름이 제거된 부위에 새살을 돋게하는 효과가 있다. 참빗살나무는 화살나무라고도 하며 그 추출물은 항암작용이 있으며 당뇨를 감소시키고 체중을 증가시키며 혈액순환을 촉진한다. 어성초는 약모밀이라고도 하며 종양이나 고름을 제거하거나 발산하며 이뇨작용이 우수하다. 겨우살이는 느릅나무, 자작나무, 버드나무 등에 기생하며 겨우살이에 포함된 알칼리성 독단백(毒蛋白) 성분이 종양세포의 성장억제 작용이 탁월하여 외국에서는 유선암, 자궁암 등의 치료에 응용하고 있으며 혈관을 확장시켜 혈액순환을 촉진한다. 동과씨는 박과에 속하는 동과(冬瓜)의 종자로서 항암활성 작용이 우수한 테르펜 화합물이 포함되어 항암작용과 이뇨작용이 우수하며 종양에 의하여 발생되는 각종 증상들을 완화시키는 효과가 있는 반면 장기복용하면 체중이 감소된다. 맹감의 뿌리는 해독 및 청혈작용과 근육 및 뼈에 대한 경련을 치료하는 효과가 있다. 비파는 항암활성 효과와 약재류의 독성에 대한 중화 효과가 우수하다. 주사련(朱砂蓮)은 포함된 아리스토록키(Aristorochy)산이 항암활성 작용이 있으며 특히 백혈구의 박테리오파제 탄식 기능을 촉진하고 이외에도 주사련의 추출액은 진통작용이 모르핀보다 우수하다. 과체는 개똥참외의 꼭지를 건조시킨 것으로 황달에대한 치료 효과가 탁월하다.As described above, the Koji mulberry extract has excellent cancer suppression and analgesic effects, and particularly, flavones contained in the tree have an excellent cytotoxic effect on cancer cells. Elm has the effect that the extract removes cancer cells and pus, and boost the flesh on the site where the cancer cells and pus is removed. Oak tree is also called arrowwood, the extract has anti-cancer effect, reduce diabetes, increase weight and promote blood circulation. Eoseongcho is also known as weak buckwheat and removes or diverges tumors or pus and has excellent diuretic effect. Mistletoe is parasitic on elm, birch and willow, and alkaline poisonous protein contained in mistletoe is excellent for inhibiting tumor cell growth. It is applied to the treatment of mammary and uterine cancer in foreign countries. It promotes blood circulation. Dong-Gwa is a seed of Dong-Gwa belonging to the gourd, which contains terpene compounds with excellent anti-cancer activity. It has excellent anti-cancer and diuretic effects and alleviates various symptoms caused by tumors. Losing weight The roots of blindness have the effect of treating detoxification and clearing and spasms to muscles and bones. Loquat has excellent anti-cancer activity and neutralizing effect on the toxicity of medicinal products. Aristorochy acid, which contains M. erysipelas, has anticancer activity. In particular, leukocytes promote the bacteriophage lamentation function. In addition, M. extracts have better analgesic activity than morphine. The overweight is the dry tap of melons, which is excellent for the treatment of jaundice.
상기한 바와 같이 각각의 천연 약재류는 그 종류에 따라 항암 효과와 함께 이와 관련되는 특정 증상에 대한 약리 작용이 우수한 반면 각각의 약재에 독성이나 부작용이 존재하므로 상기 약재류 전체를 각각 일정한 중량부로 적용하여 약재 조성물을 조성함으로써 상기 약재류의 약리 작용은 보완하고 각각의 독성이나 부작용은 중화한다. 예를 들면, 동과씨 분말은 체중을 감소시키는 부작용이 있는 반면 참빗살나무 분말은 체중을 증가시키는 효능이 있으므로 상기 동과씨 분말과 상기 참빗살나무 분말을 동시에 적용하여 약재 조성물을 조성하여 인체의 체중 감소의 부작용을 제거한다.As described above, each natural medicinal herb has an anticancer effect and a pharmacological effect on specific symptoms related thereto, while each drug has a toxic or side effect, and thus the entire medicinal herb is applied in a constant weight part. By forming a medicinal composition, the pharmacological action of the medicinal herb complements and neutralizes each toxicity or side effect. For example, copper seed powder has a side effect of reducing weight, while sesame tree powder has an effect of increasing weight, and thus, the composition of the medicinal composition is applied simultaneously with the copper seed powder and the true bark powder to form the body weight of the human body. Eliminate the side effects of reduction.
황토는 약재 조성물에서 상기한 다수개의 천연약재를 흡착하는 기재로서 굼벵이류의 발육과 영지버섯 균사체의 발아 및 영지버섯의 증식을 촉진한다.Ocher is a substrate for adsorbing a plurality of natural medicines in the medicinal composition to promote the growth of slugs and the growth of ganoderma lucidum mycelium and the growth of ganoderma lucidum mushrooms.
영지버섯은 버섯 자체가 항암 작용이 탁월하며 상기 천연 약재류로 구성된 약재 조성물을 숙주로 적용하여 재배하는 경우에 영지버섯의 항암 작용은 상기 천연 약재류에 의해 향상되면서 상기 약재류의 독성은 중화 또는 제거된다.Ganoderma lucidum mushroom has excellent anti-cancer activity, and when the medicinal composition composed of the natural medicinal herb is cultivated as a host, the anti-cancer effect of Ganoderma lucidum is enhanced by the natural medicinal herb, while the toxicity of the medicinal herb is neutralized. Removed.
<실시예 - 1>Example-1
1. 약재 조성물의 재료의 준비1. Preparation of the ingredients of the herbal composition
구지뽕나무는 잎, 줄기, 뿌리를 세척하여 완전히 건조한 다음 분쇄기로 분쇄하여 분말화(0.2~2㎜) 한다. 느릅나무와 참빗살나무도 구지뽕나무와 마찬가지로 잎, 줄기, 뿌리를 세척하여 완전히 건조한 다음 분쇄기로 분쇄하여 분말화(0.2~2㎜) 한다. 어성초와 겨우살이와 동과씨와 맹감 뿌리와 비파는 각각 별도로 세척하여 완전히 건조한 다음 분쇄기로 분쇄하여 분말화(0.2~2㎜) 한다. 주사련과 과체는 열수침출한 추출액을 적용하는데 주사련 추출액은 반응조(反應漕) 내부의 열수에 주사련 0.1 중량%를 혼합하고 100 ℃에서 2시간동안 가열하여 수용액의 부피가 80 %로 감소되면 서서히 냉각시켜 비축한다. 과체의 추출액은 반응조 내부의 열수에 건조된 과체 0.5 중량%를 혼합하고 100 ℃에서 2시간동안 가열하여 수용액의 용적이 80 %로 감소되면 서서히 냉각시켜 비축한다. 황토는 건조하여 분말화 한다.Koji mulberry leaves, stems, roots are washed, completely dried, and then pulverized by a grinder to powder (0.2 ~ 2㎜). The elm and the true comb tree, like the Koji mulberry, are washed with leaves, stems, and roots, completely dried, and then pulverized with a grinder to be powdered (0.2-2 mm). Eoseongcho, mistletoe, copper seed, blind persimmon and loquat are washed separately, completely dried, and pulverized with a grinder to be powdered (0.2 ~ 2㎜). The spinal cord and the overweight apply the hot water leached extract, which is mixed with 0.1 wt% of the hot rod in the hot water inside the reaction tank and heated at 100 ° C. for 2 hours to reduce the volume of the aqueous solution to 80%. Cool slowly and stockpile. The extract of the excess is mixed with 0.5% by weight of the dried excess in hot water in the reaction tank and heated at 100 ° C. for 2 hours, when the volume of the aqueous solution is reduced to 80% and cooled and stored slowly. Ocher is dried and powdered.
2. 약재 조성물의 구성2. Composition of medicinal composition
상기와 같이 준비된 구지뽕나무 분말 10 중량%와 느릅나무 분말 10 중량%와 참빗살나무 분말 5 중량%와 어성초 분말 5 중량%와 겨우살이 분말 5 중량%와 동과씨 분말 2 중량%와 맹감 뿌리 분말 6 중량%와 비파 분말 5 중량%와 황토 45 중량%를 교반기에 넣고 1차 교반하여 혼합한 후, 상기 과체 추출액 3 중량%와 상기 주사련 추출액 4 중량%를 첨가하고 교반하여 형성된 조성물의 80중량%와 물20중량%를 혼합한 약재 조성물을 구성한다.10% by weight of Guji mulberry powder, 10% by weight of elm tree powder, 5% by weight of sesame tree powder, 5% by weight of eochocho powder, 5% by weight of mistletoe powder, 2% by weight of copper and seed powder and 6% of persimmon root powder %, 5% by weight of loquat powder and 45% by weight of ocher were mixed in a stirrer and mixed by first stirring, and then 80% by weight of the composition formed by adding and stirring 3% by weight of the overextract extract and 4% by weight of the injection of the spinach extract A pharmaceutical composition comprising 20% by weight of water is constituted.
3. 굼벵이류의 배양3. Cultivation of slugs
온도 조절이 가능한 배양소의 내부에 형성된 배양기에 상기 약재 조성물의 분말을 일정한 두께로 살포하여 상기 분말 위에 일정한 밀도로 굼벵이류(매미, 풍뎅이, 사슴벌레, 뽕나무나방의 유충)를 이식시키고 상기 굼벵이류의 성장 속도를 저하시키기 위하여 배양소 내부의 온도를 5 ∼ 10 ℃의 범위내에서 유지하며 굼벵이류가 번데기화 되는 시기에는 번데기화 속도를 지연시키기 위하여 배양소 내부의 온도를 5 ∼ 6 ℃의 범위내에서 유지하면서 굼벵이류를 배양한다. 굼벵이류의 배양기간이 증가될수록 약성이 향상되나 상기 굼벵이의 유충기간이 한정되어 있으므로 굼벵이의 유충기간을 36월에서 42월로 한정하여 굼벵이의 유충 기간을 최대한으로 늘이고 약성을 높이는데 최소한의 시간이 요구되는 것이다.By spraying the powder of the medicinal composition to a predetermined thickness in the incubator formed inside the temperature controllable culture medium to transplant slugs (larvae of cicada, scarab, stag beetle, mulberry moth) at a certain density on the powder and of the slugs In order to reduce the growth rate, the temperature inside the culture chamber is maintained within the range of 5 to 10 ° C., and the temperature inside the culture room is within the range of 5 to 6 ° C. in order to delay the chrysalisation rate when the slugs are chrysalisated. Incubate slugs while maintaining in As the incubation period of slugs increases, the weakness improves, but the larvae duration of the slugs is limited, so the larvae duration of slugs is limited from 36 months to 42 months to increase the larvae duration and increase the weakness of the slugs. Will be.
상기와 같이 굼벵이의 유충을 36월에서 42월 동안 번데기화 되지 않도록 배양소 내부의 온도를 5 ∼ 6 ℃의 범위 내에서 지속적으로 유지시키는 환경을 조성한다.As described above, the environment of the inside of the culture medium is continuously maintained in the range of 5 to 6 ° C. so that the larvae of slugs do not become pupa for 36 to 42 months.
4. 번데기류 추출물의 구성4. Composition of pupa extract
번데기류 추출물은 열수침출법으로 구성하는데 반응조 내부의 열수(熱水)에 약재 조성물에 의하여 배양되어 성장이 완료된 굼벵이류 열수(熱水) 대비 3 중량%를 넣고 100 ℃로 가열하고 반응조 내부의 수용액의 용적이 20 %로 감소되면 가열을 중지하고 서서히 냉각하여 번데기류 추출물을 구성한다.The chrysalis extract is composed of hot water leaching method, which is incubated with hot water in the reaction tank and added 3% by weight of the slugs of hot water, which has been grown, and heated to 100 ° C., and the aqueous solution inside the reactor. When the volume is reduced to 20%, stop heating and cool slowly to form a chrysalis extract.
5. 영지버섯 추출물의 구성5. Composition of Ganoderma lucidum Extract
영지버섯 배양소의 내부에 형성된 배양대의 상부에 구지뽕나무 분말 10 중량%와 느릅나무 분말 10 중량%와 참빗살나무 분말 5 중량%와 어성초 분말 5 중량%와 겨우살이 분말 5 중량%와 동과씨 분말 2 중량%와 맹감 뿌리 분말 6 중량%와 비파 분말 5 중량%와 황토 45 중량%를 교반기에 넣고 1차 교반하여 혼합하고 이어 상기 과체 추출액 3 중량%와 상기 주사련 추출액 4 중량%를 첨가하고 교반하여 완전히 혼합하고 조성물의 수분함량이 20 %가 되는 약재 조성물의 분말을 일정한 두께로 살포하고 상기 분말에 일정한 밀도로 영지버섯 균사체를 주입하고 발아시켜 영지버섯을 재배한다.10% by weight of Guji mulberry powder, 10% by weight of elm tree powder, 5% by weight of sesame seedling powder, 5% by weight of Echo herb powder, 5% by weight of mistletoe powder and 2% by weight of Cucumber powder %, 6% by weight persimmon root powder, 5% by weight loquat powder and 45% by weight loess were added to the stirrer and mixed by first stirring. Then, 3% by weight of the excess extract and 4% by weight of the lotus extract were added and agitated completely. Mixing and spraying the powder of the medicinal composition of which the moisture content of the composition is 20% to a constant thickness, and injecting the Ganoderma lucidum mycelium at a constant density and germination to cultivate Ganoderma lucidum.
약재 조성물에서 재배된 영지버섯을 열수 대비 6중량%를 넣고 일정시간 동안 가열하고 열수 용적이 20% 감소되면 가열을 중지하고 상온에서 냉각하는 열수침출법으로 영지버섯 추출물을 구성한다.The Ganoderma lucidum mushroom cultivated in the medicinal composition is added to 6% by weight compared to hot water and heated for a certain time, when the volume of hot water is reduced by 20%, the heating is stopped and the Ganoderma lucidum extract is constituted by a hydrothermal leaching method that cools at room temperature.
6. 건강식품의 구성과 사용방법6. Composition and use of health food
상기 굼벵이류 추출물 50중량%와 영지버섯 추출물50중량%를 혼합한다. 상기와 같은 추출물의 혼합물은 중탕(重湯)되어 진액이므로 물과 혼합하여 복용할 수 있고 진액을 소량으로 복용할 수 있도록 포장하도록 한다.50% by weight of the slug extract and 50% by weight of ganoderma lucidum extract. The mixture of the extract as described above is soaked in jungtang (重 湯) can be taken by mixing with water, so that the packaging to take a small amount of the essence.
본 발명에 의한 항암 건강식품은 그 성분과 효능을 설명한 구지뽕나무 분말 10 중량%와 느릅나무 분말 10 중량%와 참빗살나무 분말 5 중량%와 어성초 분말 5 중량%와 겨우살이 분말 5 중량%와 동과씨 분말 2 중량%와 맹감 뿌리 분말 6 중량%와 비파 분말 5 중량%와 황토 45 중량%를 교반기에 넣고 1차 교반하여 혼합하고 이어 상기 과체 추출액 3 중량%와 상기 주사련 추출액 4 중량%를 첨가하고 교반하여 완전히 혼합하고 조성물의 수분함량이 20%가 유지되는 혼합물을 사료로 적용하여 굼벵이류를 배양한 상기 굼벵이류의 추출물과, 상기 약재 조성물에 영지버섯 균사체를 주입하여 재배되는 영지버섯의 추출물을 혼합하여 구성된 것으로서, 본 발명에서 이용하는 굼벵이는 다년간 저온에서 약재와 황토로 사육되었으므로 황토 자체가 제독의 기능에 의해 본 발명의 조성물 자체에 독성이 중화될 뿐 아니라 상기 조성물로 사육된 굼벵이는 신진대사 과정에서 조성물의 독성이 중화되거나 제거된다. (예; 유황(硫黃) 또는 부자(附子) 일부를 복용한 오리는 그 몸에 유황 또는 부자의 독성을 가지고 있지 않고 유황 또는 부자의 약성 만을 가지고 있음) 따라서 본 발명에 이용되는 굼벵이는 인위적으로 약성 만으로 구성된 조성물로 사육될 뿐 아니라 성충이 되는 기간을 인위적으로 연장하여 사육하였으므로 약재 조성물의 항암 및 관련작용은 유지되어 흙이나 퇴비에서 생장된 굼벵이와 비교하여 약성의 차이는 비교도 안될 정도로 큰 차이가 있으며, 본 발명에 의한 조성물로 생육시킨 영지버섯 역시 단순히 참나무에서 생육시킨 것에 비교하여 그 약성은 큰 차이가 있는 것을 논리적으로 알 수 있다. 상기와 같이 본원 발명의 조성물 만으로도 탁월한 약성을 가질 수 있으나 영지버섯의 고유 약성을 추가 하여 본 발명을 구성하므로서 약성을 향상시킬 수 있다. 따라서 본원에 의한 식품은 독성이 제거된 것으로서 신체적으로 병적인 취약성을 보완하고 그 취약성에 의한 예방에 큰 효과가 있다.The anticancer health food according to the present invention is 10% by weight of Gujimi mulberry powder, 10% by weight of elm tree powder, 5% by weight of sesame tree powder, 5% by weight of eocho vinegar powder and 5% by weight of mistletoe powder and copper seeds which explained the ingredients and efficacy 2% by weight of powder, 6% by weight of persimmon root powder, 5% by weight of loquat powder and 45% by weight of loess were added to the stirrer and mixed by first stirring, followed by adding 3% by weight of the overextract extract and 4% by weight of the extract After mixing thoroughly by mixing and maintaining a 20% water content of the composition as a feed, the extract of the slugs cultivated slugs and the Ganoderma lucidum mycelium cultivated by injecting the Ganoderma lucidum mycelium into the medicinal composition The slugs used in the present invention have been rearranged as medicinal herbs and loess at low temperatures for many years. Not only it is neutralizing the toxic composition self-slugs bred in the composition is removed the composition of the Toxicity neutralization or from metabolic processes. (E.g. ducks that have taken some sulfur or riches do not have sulfur or rich toxicity in their bodies, only sulfur or weakness of the rich). Therefore, slugs used in the present invention are artificially Not only was it bred into a composition composed of weakness but also artificially extended to adulthood period, so the anticancer and related action of the medicinal composition is maintained so that the difference in weakness is incomparable compared to slugs grown in soil or compost. In addition, the Ganoderma lucidum grown with the composition according to the present invention can also be logically found that the weakness compared to that simply grown in oak. Although the composition of the present invention as described above may have excellent weakness, it can improve the weakness by configuring the present invention by adding the inherent weakness of Ganoderma lucidum. Therefore, the food according to the present application has a great effect on supplementing physically vulnerable vulnerabilities and preventing the vulnerabilities by eliminating toxicity.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0045211A KR100377252B1 (en) | 2000-08-04 | 2000-08-04 | Health food for anticancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0045211A KR100377252B1 (en) | 2000-08-04 | 2000-08-04 | Health food for anticancer |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20000072134A KR20000072134A (en) | 2000-12-05 |
KR100377252B1 true KR100377252B1 (en) | 2003-03-26 |
Family
ID=19681715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2000-0045211A KR100377252B1 (en) | 2000-08-04 | 2000-08-04 | Health food for anticancer |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100377252B1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010110225A (en) * | 2001-10-06 | 2001-12-12 | 서동주 | method of cultivate vegetable or grain using elm |
KR101277345B1 (en) * | 2011-02-21 | 2013-06-20 | 윤철호 | Breeding method of cicada larva using cudrania tricuspidata and cicada larva breeded by cudrania tricuspidata |
KR20180088217A (en) | 2017-01-26 | 2018-08-03 | 양경하 | Manufacturing method of cracker containing white grub and cracker containing white grub by the same |
KR20200056832A (en) | 2018-11-15 | 2020-05-25 | (주)화인에프티 | Composition for Anti-diabetic comprising Hydrorized Extract of Glub |
KR20220012532A (en) | 2020-07-23 | 2022-02-04 | 에이치엠오건강드림영농조합법인 | Health food composition with significantly improved blood sugar lowering and diabetes prevention effect, and slug breeding method therefor |
KR20220059692A (en) | 2020-11-03 | 2022-05-10 | ㈜농업회사법인 힘쎈 | Method for the production of fatigue recovery capsule with larva |
KR20230099528A (en) | 2021-12-27 | 2023-07-04 | 국립낙동강생물자원관 | Composition for inhancing immune function containing extract of Protaetia brevitarsis seulensis larvae and Method of producing the composition |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100414187B1 (en) * | 2001-06-26 | 2004-01-07 | 대한민국 | Hepatoprotective extract derived from Protaetia brevitarsis and its use |
KR101041773B1 (en) * | 2009-04-21 | 2011-06-17 | 김애자 | A functional health drink and methode of the same |
KR101616688B1 (en) | 2015-10-20 | 2016-04-28 | 연광흠 | Manufacturing method of functional foods from grub |
KR101726741B1 (en) * | 2016-08-01 | 2017-04-13 | 김우성 | Manufacturing method of composition having cicada larva and jujube and natural beverage and pills having thereof |
KR20180064351A (en) | 2018-05-30 | 2018-06-14 | 씨와열매농장(주)농업회사법인 | Method for manufacturing confectionery containing white grub powder |
KR102211035B1 (en) * | 2020-02-24 | 2021-02-03 | 한국원자력연구원 | Composition comprising insect extract for treating and improving cancer |
-
2000
- 2000-08-04 KR KR10-2000-0045211A patent/KR100377252B1/en not_active IP Right Cessation
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010110225A (en) * | 2001-10-06 | 2001-12-12 | 서동주 | method of cultivate vegetable or grain using elm |
KR101277345B1 (en) * | 2011-02-21 | 2013-06-20 | 윤철호 | Breeding method of cicada larva using cudrania tricuspidata and cicada larva breeded by cudrania tricuspidata |
KR20180088217A (en) | 2017-01-26 | 2018-08-03 | 양경하 | Manufacturing method of cracker containing white grub and cracker containing white grub by the same |
KR20200056832A (en) | 2018-11-15 | 2020-05-25 | (주)화인에프티 | Composition for Anti-diabetic comprising Hydrorized Extract of Glub |
KR20220012532A (en) | 2020-07-23 | 2022-02-04 | 에이치엠오건강드림영농조합법인 | Health food composition with significantly improved blood sugar lowering and diabetes prevention effect, and slug breeding method therefor |
KR20220059692A (en) | 2020-11-03 | 2022-05-10 | ㈜농업회사법인 힘쎈 | Method for the production of fatigue recovery capsule with larva |
KR20230099528A (en) | 2021-12-27 | 2023-07-04 | 국립낙동강생물자원관 | Composition for inhancing immune function containing extract of Protaetia brevitarsis seulensis larvae and Method of producing the composition |
Also Published As
Publication number | Publication date |
---|---|
KR20000072134A (en) | 2000-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kumar et al. | Recent trends in potential traditional Indian herbs Emblica officinalis and its medicinal importance | |
KR100377252B1 (en) | Health food for anticancer | |
CN106489836A (en) | A kind of pig cultivation method of preventing and treating parasite | |
CN106718732A (en) | A kind of dedicated substrate of preserved vegetable nursery | |
CN107445747A (en) | A kind of fertilizer for preventing and treating foliar pest and preparation method thereof | |
KR20170033470A (en) | chive cultivation method and chive | |
KR20120035581A (en) | Complex enzyme | |
KR20150074549A (en) | Poisson component is contained in a large amount of fruit cultivation and functional method | |
Wickens et al. | A search for novel biologically active compounds in the phyllodes of Acacia species. | |
CN108812549A (en) | The propagation method of golden head centipede | |
KR102371359B1 (en) | Application composition for controlling pests and diseases of trees | |
CN104663585B (en) | Food toad return of spring worm breeding method and obtained pharmaceutical raw material | |
KR20110091959A (en) | Anhydrous lactobacillus fermentation health function food composition with cancer curing improvements and its preparation method | |
KR102016609B1 (en) | Nutritional Supplements for Grape Cultivation comprising Coffee Resudual Product, Charcoal Powder and Microbial Agent and Manufacturing method thereof | |
KR100463959B1 (en) | a Compost by use of Duck's Manure and Method for Preparing the Same | |
CN107624464A (en) | The method for the crops enriched using far infrared cultivation nutrient composition | |
KR101394028B1 (en) | Skin Diseases drug therapy and its manufacturing method | |
CN105272610A (en) | Controlled-release fertilizer for Chinese yams and preparation method of fertilizer | |
CN106034606B (en) | A kind of prevention and disposition method of pseudo-ginseng field integrated disease | |
CN110292053A (en) | A kind of composite plant growth regulator and its application | |
JP3031918B1 (en) | Condiment and method for producing condiment, and food, soap and fertilizer containing condiment | |
KR102380409B1 (en) | Balsam pear cultivation composition using banaba leaf and balsam pear, and its cultivation method using same | |
KR102401616B1 (en) | Amino acid composite fertilizer using boiled silk worm larvae and manufacturing method thereof | |
CN108752101A (en) | A kind of special spray of Desmodium styracifolium | |
KR102412030B1 (en) | Cultivation method of barley sprout with increased saponarin content by elicitor treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130306 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20140409 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20150310 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20160304 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20170313 Year of fee payment: 15 |
|
LAPS | Lapse due to unpaid annual fee |